Exane Derivatives’s Virgin Galactic SPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding SPCE
CS
Exane Derivatives's SPCE Position: Q2 2022 in Review
Exane Derivatives sold out of Virgin Galactic (SPCE) in Q2 2022, closing a stake of 119 shares — an estimated $23.5K sold.
Exane Derivatives first reported a position in SPCE in Q3 2020 and held it in 6 quarters. The position peaked at $255K in Q1 2021. 267 funds tracked by Wall St. Rank hold SPCE as of Q2 2022.
- Exane Derivatives reported no remaining Virgin Galactic position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 119 Virgin Galactic shares in Q2 2022, an estimated $23.5K.
- Exane Derivatives first reported a position in Virgin Galactic in Q3 2020 and held it in 6 quarters.
- Exane Derivatives's Virgin Galactic position peaked at $255K in Q1 2021.
- 267 funds tracked by Wall St. Rank held Virgin Galactic as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.